Pfizer Wins Dismissal of 23 Prempro Lawsuits

For Pfizer (PFE), most of the news lately on the legal front has been bad. The pharmaceutical giant has faced setbacks in and out of courtrooms across the nation, and in September agreed to pay a record $2.3 billion to settle civil and criminal charges in a case about off-label drug promotion. But this week, Pfizer got a bit of good news regarding some of the hormone replacement therapy cases against it. A New York judge dismissed at least 23 lawsuits against Pfizer units Wyeth and Pharmacia & Upjohn, as well as Teva Pharmaceutical Industries Ltd. (TEVA), filed by women who claimed that the menopause drugs Prempro, Premarin and Provera had caused their breast cancers.

%%DynaPub-Enhancement class="enhancement contentType-HTML Content fragmentId-1 payloadId-61603 alignment-right size-small"%%